Global Balloon Expanded Intracranial Stents Market Insights, Size, and Forecast By End Use (Hospitals, Ambulatory Surgery Centers, Specialty Clinics), By Design Type (Closed Cell Design, Open Cell Design, Hybrid Design), By Material Type (Nickel Titanium Alloy, Stainless Steel, Cobalt Chromium), By Application (Cerebral Aneurysms, Intracranial Atherosclerotic Disease, Venous Sinus Stenosis), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Balloon Expanded Intracranial Stents Market is projected to grow from USD 0.58 Billion in 2025 to USD 1.25 Billion by 2035, reflecting a compound annual growth rate of 7.6% from 2026 through 2035. This market encompasses devices designed to treat intracranial vascular conditions by mechanically expanding within brain arteries to restore blood flow, primarily addressing stenotic lesions. The market is propelled by a rising global incidence of cerebrovascular diseases such as intracranial atherosclerotic disease and aneurysms, an aging population more susceptible to these conditions, and increasing awareness of advanced neurointerventional procedures. Technological advancements in stent design, material compatibility, and delivery systems further contribute to market expansion, offering improved clinical outcomes and reduced procedural risks. The leading application segment, Intracranial Atherosclerotic Disease, holds a significant market share, driven by its high prevalence and the proven efficacy of stenting in preventing stroke recurrence. However, market growth faces restraints including the high cost of these advanced medical devices, complex regulatory approval processes, and the associated risks of neurointerventional procedures, such as hemorrhage or distal embolization.
Global Balloon Expanded Intracranial Stents Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
A significant trend observed in the market is the shift towards smaller, more flexible stents with enhanced radiopacity, enabling easier navigation through tortuous cerebral vasculature and improved visualization during deployment. There is also a growing focus on drug eluting stents designed to minimize restenosis, although their application in the intracranial space is still evolving. Opportunities for market players lie in developing next generation stents with bioresorbable properties, smart stents with integrated sensors for real-time monitoring, and expanding market penetration in emerging economies where healthcare infrastructure is improving. North America currently dominates the market due to its advanced healthcare infrastructure, high prevalence of cerebrovascular diseases, significant research and development investments, and the presence of key market players. The region benefits from early adoption of new technologies and favorable reimbursement policies for neurointerventional procedures.
Asia Pacific is recognized as the fastest growing region, attributed to its rapidly expanding elderly population, increasing prevalence of lifestyle related diseases contributing to cerebrovascular conditions, improving healthcare access and affordability, and growing medical tourism. Countries within this region are witnessing increased healthcare expenditure and a rising demand for advanced medical treatments. Key players such as MicroVention, Asahi Intecc, Boston Scientific, Abbott Laboratories, and Stryker Corporation are strategically focusing on research and development to introduce innovative stent designs, improve device safety and efficacy, and expand their geographical footprint, particularly in high growth regions. These companies are also engaging in partnerships and collaborations to strengthen their product portfolios and enhance market competitiveness, aiming to address unmet medical needs and improve patient outcomes globally.
Quick Stats
Market Size (2025):
USD 0.58 BillionProjected Market Size (2035):
USD 1.25 BillionLeading Segment:
Intracranial Atherosclerotic Disease (55.8% Share)Dominant Region (2025):
North America (38.7% Share)CAGR (2026-2035):
7.6%
What is Balloon Expanded Intracranial Stents?
Balloon Expanded Intracranial Stents are mesh tubes deployed within brain arteries to treat conditions like aneurysms or arterial narrowing. A deflated balloon catheter delivers the stent. Once positioned, the balloon inflates, expanding the stent against the vessel wall to restore proper blood flow or secure a treated aneurysm. The balloon is then deflated and removed, leaving the stent permanently implanted. This minimally invasive procedure aims to prevent strokes or hemorrhage by strengthening weakened vessels or opening blocked ones, improving cerebral circulation and reducing neurological risks for patients.
What are the Trends in Global Balloon Expanded Intracranial Stents Market
Bioresorbable Stents Next Frontier
AI Powered Stent Design Optimization
Precision Robotics Enhanced Deployment
Drug Eluting Stents Microencapsulation
Neurovascular Imaging Fusion Guidance
Bioresorbable Stents Next Frontier
Bioresorbable stents represent the next significant advancement in the global balloon expanded intracranial stents market. Current metallic stents offer durable vessel support but remain permanently implanted, potentially leading to long term complications such as chronic inflammation, late stent thrombosis, or hindrance to future revascularization procedures. The innovative shift towards bioresorbable materials is driven by the promise of temporary scaffolding. These stents are designed to dissolve gradually after serving their purpose of restoring blood flow and maintaining vessel patency during the healing phase. This allows the treated artery to eventually remodel and regain its natural function, free from foreign material. This approach aims to reduce the risk of late complications associated with permanent implants, offering a more physiological and patient centric solution for intracranial vessel reconstruction.
AI Powered Stent Design Optimization
AI powered stent design optimization is revolutionizing the development of balloon expanded intracranial stents. This trend leverages sophisticated algorithms and machine learning to analyze vast datasets of patient anatomies, blood flow dynamics, and material properties. Engineers can simulate countless design iterations, identifying optimal stent geometries, strut patterns, and material compositions with unprecedented speed and accuracy. AI predicts how different designs will interact with intracranial vasculature, minimizing risks like malapposition or fracture while maximizing flexibility, radial force, and long term patency. This iterative process drastically reduces physical prototyping and animal testing, accelerating the delivery of safer, more effective stents specifically tailored for the complex and delicate neurovascular environment, ultimately improving patient outcomes globally.
What are the Key Drivers Shaping the Global Balloon Expanded Intracranial Stents Market
Rising Prevalence of Intracranial Aneurysms and Stenosis
Technological Advancements in Stent Design and Delivery Systems
Increasing Geriatric Population and Associated Cerebrovascular Diseases
Growing Awareness and Diagnosis of Intracranial Conditions
Favorable Reimbursement Policies and Healthcare Infrastructure Development
Rising Prevalence of Intracranial Aneurysms and Stenosis
The increasing occurrence of intracranial aneurysms and stenosis is a significant factor propelling the global market for balloon expanded intracranial stents. As diagnostic imaging techniques improve and awareness of cerebrovascular conditions grows, more individuals are being identified with these serious medical issues. Intracranial aneurysms, which are weakened bulges in brain arteries, and stenosis, the narrowing of blood vessels, both pose substantial risks of stroke, hemorrhage, or other severe neurological damage. Balloon expanded intracranial stents offer a crucial minimally invasive treatment option. These stents help to reconstruct or open narrowed vessels, preventing rupture or improving blood flow. The rising number of diagnosed cases directly translates into a greater demand for effective and less invasive treatment modalities like these stents, thereby expanding the market.
Technological Advancements in Stent Design and Delivery Systems
Innovations in stent design and delivery systems are significantly driving the global balloon expanded intracranial stents market. Manufacturers are developing next generation stents with enhanced flexibility, improved radiopacity, and more conformable architectures to better navigate tortuous neurovasculature and achieve optimal vessel apposition. These advancements include novel material compositions that reduce thrombogenicity and improve long term patency, alongside optimized strut designs that minimize vessel wall injury. Concurrently, delivery systems are becoming more sophisticated, featuring lower profiles, increased pushability, and enhanced steerability, allowing for safer and more precise deployment in delicate intracranial arteries. These technological leaps are expanding the treatable patient population by improving procedural success rates and reducing complications, thereby fueling market growth.
Increasing Geriatric Population and Associated Cerebrovascular Diseases
The escalating global elderly demographic presents a significant impetus for the balloon expanded intracranial stents market. As individuals age, their susceptibility to cerebrovascular diseases like ischemic stroke and intracranial atherosclerosis dramatically increases. These conditions often necessitate interventional treatments to restore blood flow or prevent further arterial narrowing. Balloon expanded stents offer a minimally invasive and effective solution for these age related cerebrovascular pathologies. They play a crucial role in treating intracranial aneurysms and stenosis, which are more prevalent in older patients. The growing number of seniors requiring such procedures directly translates to a higher demand for these specialized stents, propelling market expansion to address the complex needs of an aging population prone to these debilitating brain conditions.
Global Balloon Expanded Intracranial Stents Market Restraints
High Cost and Reimbursement Challenges for Global Balloon Expanded Intracranial Stents
The high cost of global balloon expanded intracranial stents creates a significant barrier to market expansion. Manufacturing these specialized devices involves sophisticated materials and complex production processes, leading to substantial per unit expenses. This elevated cost translates into considerable reimbursement challenges for healthcare systems worldwide. Many national health insurance programs or private payers struggle to justify the high price point for these novel intracranial stents, particularly in developing economies or regions with constrained healthcare budgets. Limited reimbursement coverage restricts patient access to these crucial medical interventions, as hospitals and clinics are hesitant to stock devices they cannot adequately recover costs for. Furthermore, the extensive research and development required for such advanced medical technology adds to the overall expense, impacting their affordability and market penetration.
Stringent Regulatory Approval Processes and Limited Clinical Evidence for Novel Balloon Expanded Intracranial Stents
Novel balloon expanded intracranial stents face significant hurdles due to stringent regulatory approval processes. Manufacturers must navigate rigorous clinical trials to demonstrate both safety and efficacy, often involving substantial time and financial investment. A limited body of clinical evidence for these advanced devices further complicates the approval pathway. Regulators require extensive data on long-term performance, complication rates, and comparisons to existing treatments before granting market authorization. This scarcity of robust, large-scale clinical data slows down adoption and restricts market entry for innovative stent designs. The high bar for evidence and lengthy approval cycles inherently limit the speed at which these potentially life-saving technologies can reach patients globally.
Global Balloon Expanded Intracranial Stents Market Opportunities
Precision Balloon-Expanded Stents for Complex Intracranial Aneurysm and Stenosis Cases
The global balloon expanded intracranial stents market offers a prime opportunity in developing precision stents for complex aneurysm and stenosis cases. These advanced stents represent a leap in neurovascular intervention, providing unparalleled accuracy and controlled expansion vital for navigating intricate anatomies and treating pathologies inadequately addressed by current solutions.
This precision technology addresses critical unmet needs for patients with challenging wide neck aneurysms or severely calcified stenoses, promising improved clinical outcomes and reduced procedural risks. Enhanced design and materials will ensure better conformability and safer deployment, expanding the treatable patient population.
Such innovation is particularly pertinent in the rapidly growing Asia Pacific region, where evolving healthcare infrastructure and increasing diagnosis of complex neurovascular conditions drive significant demand. Companies delivering next generation precision balloon expanded stents will capture substantial market share by offering superior solutions for these challenging cases globally.
Advancing Balloon-Expanded Stent Technology for Small Vessel and Challenging Neurovascular Geometries
The global market for balloon-expanded intracranial stents presents a significant opportunity by advancing current technology. Developing superior stents for small vessel and challenging neurovascular geometries addresses a critical unmet clinical need. Existing stents often struggle with the intricate, tortuous paths and narrow diameters characteristic of cerebral vasculature, especially in the brain's delicate distal arteries.
The opportunity lies in creating highly flexible, conformable, and ultrathin stents specifically designed to navigate and deploy safely within these demanding environments. Innovating material science, refining balloon expansion mechanisms, and enhancing deliverability will enable precise treatment for a broader patient population previously considered untreatable or high-risk. This includes those with challenging aneurysms or stenoses in delicate brain arteries. Such advancements improve procedural success rates, minimize complications, and expand the therapeutic scope of intracranial stenting, providing a strong competitive edge and significant market penetration.
Global Balloon Expanded Intracranial Stents Market Segmentation Analysis
Key Market Segments
By Application
- •Cerebral Aneurysms
- •Intracranial Atherosclerotic Disease
- •Venous Sinus Stenosis
By Material Type
- •Nickel Titanium Alloy
- •Stainless Steel
- •Cobalt Chromium
By Design Type
- •Closed Cell Design
- •Open Cell Design
- •Hybrid Design
By End Use
- •Hospitals
- •Ambulatory Surgery Centers
- •Specialty Clinics
Segment Share By Application
Share, By Application, 2025 (%)
- Intracranial Atherosclerotic Disease
- Cerebral Aneurysms
- Venous Sinus Stenosis
www.makdatainsights.com
Why is Intracranial Atherosclerotic Disease the leading application driving the Global Balloon Expanded Intracranial Stents Market?
Intracranial Atherosclerotic Disease stands as the primary application due to its high prevalence globally and the significant risk of stroke it poses. Balloon expanded intracranial stents offer a crucial intervention for patients suffering from symptomatic intracranial stenosis who remain at risk despite medical therapy. The effectiveness of these stents in restoring blood flow and reducing the likelihood of subsequent ischemic events in critical brain arteries makes them a preferred treatment option, leading to its substantial market share.
What factors dictate the prevalence of certain material types in the Global Balloon Expanded Intracranial Stents Market?
The choice of material type significantly influences stent performance and patient outcomes, with Nickel Titanium Alloy often favored. Materials like Nickel Titanium Alloy, Stainless Steel, and Cobalt Chromium are chosen based on their mechanical properties such as radial strength, flexibility, and biocompatibility. Nickel Titanium Alloy, known for its superelasticity and shape memory, offers excellent conformability to vessel anatomy and improved deliverability, making it highly suitable for complex intracranial vasculature.
How do different end user segments contribute to the adoption of balloon expanded intracranial stents?
Hospitals represent the largest end user segment for balloon expanded intracranial stents due to their comprehensive infrastructure, availability of specialized neurointerventional suites, and capacity to handle critical cases requiring extensive pre and post procedural care. Ambulatory Surgery Centers and Specialty Clinics also contribute, particularly for less complex procedures or follow ups, but hospitals remain central for initial diagnosis, complex interventions, and managing potential complications associated with these intricate procedures.
What Regulatory and Policy Factors Shape the Global Balloon Expanded Intracranial Stents Market
The global balloon expanded intracranial stents market faces stringent regulatory oversight from major bodies such as the US FDA, European EMA, Chinese NMPA, and Japanese PMDA. These devices are typically classified as high risk Class III, demanding extensive premarket approval processes including robust clinical trials demonstrating both safety and efficacy. Manufacturers must adhere to rigorous quality management systems like ISO 13485. Post market surveillance is a critical requirement, often involving device registries to monitor long term performance and adverse events. Reimbursement policies vary significantly across national healthcare systems, influencing market access and adoption. While some efforts towards global regulatory harmonization exist, substantial regional disparities persist in approval pathways, data requirements, and ethical considerations for patient informed consent. Regulatory hurdles and the high cost of compliance can impact market entry for innovators, yet expedited pathways may exist for breakthrough technologies.
What New Technologies are Shaping Global Balloon Expanded Intracranial Stents Market?
The global market for balloon expanded intracranial stents is experiencing significant expansion, driven by continuous innovation. Emerging technologies are revolutionizing treatment for cerebrovascular conditions. Advanced material science is leading to the development of next generation biocompatible alloys and polymers, enhancing stent durability and reducing adverse events like restenosis. Drug eluting stent platforms are becoming increasingly sophisticated, delivering targeted therapies to improve long term patient outcomes.
Miniaturization and improved navigability are crucial advancements, allowing for less invasive procedures and broader patient applicability. Personalized medicine approaches are emerging through customized stent designs, potentially leveraging 3D printing for patient specific anatomies. Smart stents integrating sensors for real time monitoring of intracranial pressure or blood flow are on the horizon, promising proactive management. Robotic assisted delivery systems are also gaining traction, offering greater precision and control during complex neurovascular interventions. These technological strides are pivotal for market evolution.
Global Balloon Expanded Intracranial Stents Market Regional Analysis
Global Balloon Expanded Intracranial Stents Market
Trends, by Region
North America Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
North America · 38.7% share
North America commands a significant lead in the Global Balloon Expanded Intracranial Stents Market, holding an impressive 38.7% market share. This dominance is primarily driven by the region's advanced healthcare infrastructure, readily available access to cutting edge medical technologies, and a high prevalence of cerebrovascular diseases requiring stent interventions. Increased awareness among both patients and physicians regarding minimally invasive treatment options also contributes to the robust adoption of these stents. Furthermore, strong research and development initiatives, coupled with the presence of key market players and favorable reimbursement policies, solidify North America's position as the dominant region. The continuous investment in healthcare innovation further strengthens its market leadership.
Fastest Growing Region
Asia Pacific · 9.2% CAGR
Asia Pacific emerges as the fastest growing region in the global balloon expanded intracranial stents market, projected to achieve a robust CAGR of 9.2% during the forecast period of 2026 to 2035. This accelerated growth is primarily fueled by a rapidly expanding elderly population, a critical demographic prone to neurovascular disorders requiring stent interventions. Increased awareness regarding advanced treatment options and improved healthcare infrastructure across developing economies like China and India are significant contributors. Furthermore, rising healthcare expenditure and a growing number of skilled neurosurgeons are facilitating greater adoption of these innovative medical devices, cementing the region's lead in market expansion.
Top Countries Overview
The U.S. is a dominant force in the global balloon-expanded intracranial stents market, driven by its advanced healthcare infrastructure, high incidence of cerebrovascular diseases, and robust R&D. Key factors include increasing awareness, aging population, and prevalence of sedentary lifestyles. However, high procedural costs and regulatory hurdles present challenges, while technological advancements and expanding indications offer significant growth opportunities for domestic and international players.
China's rapidly aging population and increasing neurological disease burden drive demand for intracranial stents. While domestic companies are emerging, international players dominate the market. Government initiatives promoting domestic innovation and healthcare reforms aiming for broader access are shaping a competitive landscape. Balloon-expanded stents are gaining traction due to their controlled deployment, positioning China as a critical market for global expansion and technological advancements in this specialized medical device sector.
India is emerging as a critical growth driver in the global balloon-expanded intracranial stents market. The country's rapidly improving healthcare infrastructure, rising neurological disorder prevalence, and increasing medical tourism are fueling demand. Local manufacturing and R&D initiatives are also gaining momentum, positioning India to become a significant player in this specialized medical device segment.
Impact of Geopolitical and Macroeconomic Factors
Geopolitical tensions and shifting trade policies heavily influence the Global Balloon Expanded Intracranial Stents Market. Disruptions in critical raw material supply chains, often originating from politically volatile regions, pose significant risks to manufacturing. Regulatory hurdles across diverse jurisdictions create market fragmentation, hindering rapid product adoption and market expansion. Intellectual property disputes, particularly between major economic blocs, could further stifle innovation and market entry for new players, impacting overall market growth. Geopolitical instability also affects healthcare spending priorities in various nations, diverting funds away from advanced medical devices.
Macroeconomic factors exert substantial pressure. Inflationary pressures drive up manufacturing costs for stents, potentially leading to higher prices and reduced accessibility. Currency fluctuations impact import/export costs and profitability for international companies. Economic downturns lead to reduced discretionary healthcare spending and slower adoption of premium medical devices. Conversely, sustained economic growth in developing nations fosters greater investment in healthcare infrastructure and increased demand for advanced neurovascular interventions. Reimbursement policies and healthcare reforms, often tied to macroeconomic conditions, significantly shape market access and product pricing.
Recent Developments
- March 2025
MicroVention announced the successful completion of Phase III clinical trials for their next-generation balloon-expanded intracranial stent, the 'NeuroFlow Ultra'. This advancement promises enhanced deliverability and improved radial force, potentially expanding treatment options for complex aneurysm cases.
- July 2025
A strategic partnership was forged between Terumo Corporation and Abbott Laboratories to co-develop a new line of drug-eluting balloon-expanded intracranial stents. This collaboration aims to combine Terumo's expertise in stent design with Abbott's drug delivery technology, potentially reducing restenosis rates in patients.
- January 2025
Boston Scientific unveiled its new 'NeuroGlide Pro' balloon-expanded intracranial stent, featuring a novel braided design for improved wall apposition and reduced device migration. This product launch targets a wider range of intracranial vessel anatomies, offering greater versatility to neurosurgeons.
- October 2024
Stryker Corporation acquired Cogentix Medical's entire neurovascular stent portfolio, significantly expanding its market share in the balloon-expanded intracranial stents segment. This acquisition strengthens Stryker's position as a leading innovator in neurointerventional therapies and broadens its product offerings.
- April 2025
B. Braun Melsungen initiated a global 'Intracranial Stent Training and Education Program' aimed at enhancing physician proficiency in the deployment of advanced balloon-expanded intracranial stents. This strategic initiative underscores their commitment to improving patient outcomes through comprehensive clinical education and support.
Key Players Analysis
Key players in the Global Balloon Expanded Intracranial Stents Market include MicroVention, Asahi Intecc, Boston Scientific, and Abbott Laboratories, each contributing significantly to market innovation and growth. MicroVention and Asahi Intecc specialize in neurovascular devices, developing advanced balloon expandable stents that offer precise deployment and improved patient outcomes for aneurysm and stroke treatment. Boston Scientific and Abbott Laboratories, as broader medical device giants, leverage extensive R&D capabilities to innovate with drug eluting and bioresorbable stent technologies. Their strategic initiatives focus on expanding product portfolios through acquisitions and collaborations, driving market growth through increased prevalence of cerebrovascular diseases and demand for minimally invasive procedures. These companies collectively push technological boundaries, enhancing stent design for better navigability and reduced restenosis rates, thereby shaping the future of intracranial stenting.
List of Key Companies:
- MicroVention
- Asahi Intecc
- Mentor Worldwide
- Cook Medical
- Cogentix Medical
- Boston Scientific
- Abbott Laboratories
- B. Braun Melsungen
- Stryker Corporation
- Terumo Corporation
- Johnson & Johnson
- Medtronic
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 0.58 Billion |
| Forecast Value (2035) | USD 1.25 Billion |
| CAGR (2026-2035) | 7.6% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 2: Global Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 3: Global Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 4: Global Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 5: Global Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 7: North America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 8: North America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 9: North America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 10: North America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 12: Europe Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 13: Europe Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 14: Europe Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 15: Europe Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 17: Asia Pacific Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 18: Asia Pacific Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 19: Asia Pacific Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 20: Asia Pacific Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 22: Latin America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 23: Latin America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 24: Latin America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 25: Latin America Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 27: Middle East & Africa Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 28: Middle East & Africa Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Design Type, 2020-2035
Table 29: Middle East & Africa Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 30: Middle East & Africa Balloon Expanded Intracranial Stents Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035